Thursday, 28 October 2021

Covaxin to get WHO approval this week as per reports

Covaxin to get WHO approval this week as per reports

The World Health Organisation is setting to recognize Covaxin, India’s first home Covid19 vaccine. Within a week, it will bring relief to millions of its recipients who have been in a fix over the local opportunity for international travelers.

Covishield, the other Covid-19 vaccine used mainly in India’s national Covid vaccination operation, had received the use of emergency listing by the WHO several months back. Still, Sputnik V, another vaccine used in India, is also not recognized yet by WHO.

Sources said that Bharat Biotech, a maker of Covaxin, had shared the relevant data from the clinical trials with the world health agency over the past few months.

The WHO approval procedure for a vaccine consists of four steps, including acceptance of the vaccine maker’s expression of interest, a pre-submission meeting between WHO and manufacturer, acceptance of the dossier for evaluation by the agency, the decision on the status of assessment, and final approval based on data submitted.

The WHO and Bharat Biotech had both earlier said that a decision on the recognition of the whole inactivated virus-based vaccine was likely in August as complete test data has been submitting.

Covaxin to get WHO approval this week as per reports 1unsplash image

Read More : Countries with COVID-19 vaccine compulsory

Covaxin is yet to be authorized in the Western countries, leading to a hassle for thousands of students, their parents,

Due to lack of WHO approval, those who have received both doses of Covaxin are seeing as without vaccination.

Many countries and have been approaching by public authorities in various states to resolve the issue.

Officials confirmed that the Union health ministry has been pushing for the WHO approval of the vaccine, jointly developed by the ICMR, and last month in his meeting with its chief scientist Soumya Swaminathan health minister Mansukh Mandwiya discussed the issue.

As per the figure released by Bharat Biotech in its late-stage clinical test, the vaccine, developed jointly operated with ICMR, was found to be nearly 78% effective against symptomatic infection. However, many experts say its real-world efficacy and efficacy against more transmissible variants still need to be assessed.

The WHO has already approved COVID-19 vaccines like

Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna, and Sinopharm.

Follow Us

Popular Post

School in Delhi to re-open from 1st November

School in Delhi to re-open from 1st November

Farhan Sayyed Oct 27, 2021 Politics

After more than eighteen months, all schools in Delhi will be permitted to re-open for all classes, including at the primary level—from 1st November. ...